Literature DB >> 26403417

Patients are dissatisfied with information provision: perceived information provision and quality of life in prostate cancer patients.

Romy E D Lamers1, Maarten Cuypers2, Olga Husson3,4, Marieke de Vries2, Paul J M Kil1, J L H Ruud Bosch5, Lonneke V van de Poll-Franse3,4.   

Abstract

OBJECTIVE: To determine the satisfaction with information received by prostate cancer survivors and associations with health-related quality of life (HRQoL) and illness perception.
METHODS: A cross-sectional study was performed among 999 patients diagnosed between 2006 and 2009. All patients received a questionnaire on HRQoL (EORTC QLQ-C30), illness perception (B-IPQ) and satisfaction with information provision (EORTC QLQ-INFO-25). Multivariate regression analyses were performed to assess the association between satisfaction with information provision and HRQoL as well as illness perception.
RESULTS: Response rate was 70% (N = 697), 34% (N = 222) indicated to be dissatisfied with the information received. Multivariate linear regression analyses showed a significant positive association between satisfaction with information provision and global health (P = <0.001), emotional functioning (P = 0.004), social functioning (P = 0.027), physical functioning (P = 0.002) and role functioning (P = 0.001). Satisfaction was negatively associated with illness perception subscales on consequences (P = 0.020), timeline (P = 0.031), personal control (P = 0.013), treatment control (P < 0.001), illness concern (P < 0.001), coherence (P = 0.001) and emotional representation (P = 0.004). Hence, more satisfied patients reported fewer consequences of disease, illness concern and emotional representation, but higher personal and treatment control and coherence.
CONCLUSIONS: A third of all prostate cancer survivors reported to be dissatisfied with the information received and scored worse on HRQoL and illness perception. A prospective randomized study is needed to study the effect of an intervention that improves information provision on HRQoL and illness perception outcomes.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  health related quality of life; illness perception; oncology; patient information satisfaction; prostate cancer

Mesh:

Year:  2015        PMID: 26403417     DOI: 10.1002/pon.3981

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  11 in total

1.  Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.

Authors:  Valentin H Meissner; Kathleen Herkommer; Birgitt Marten-Mittag; Jürgen E Gschwend; Andreas Dinkel
Journal:  J Cancer Surviv       Date:  2017-05-21       Impact factor: 4.442

2.  Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study.

Authors:  Amy Downing; Penny Wright; Richard Wagland; Eila Watson; Therese Kearney; Rebecca Mottram; Majorie Allen; Victoria Cairnduff; Oonagh McSorley; Hugh Butcher; Luke Hounsome; Conan Donnelly; Peter Selby; Paul Kind; William Cross; James W H Catto; Dyfed Huws; David H Brewster; Emma McNair; Lauren Matheson; Carol Rivas; Johana Nayoan; Mike Horton; Jessica Corner; Julia Verne; Anna Gavin; Adam W Glaser
Journal:  BMJ Open       Date:  2016-12-07       Impact factor: 2.692

3.  Patient satisfaction with information on oral anticancer agent use.

Authors:  Christel C L M Boons; Lonneke Timmers; Natasja M van Schoor; Eleonora L Swart; N Harry Hendrikse; Jeroen J W M Janssen; Jacqueline G Hugtenburg
Journal:  Cancer Med       Date:  2017-11-23       Impact factor: 4.452

4.  Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making.

Authors:  Anshu Ankolekar; Ben G L Vanneste; Esther Bloemen-van Gurp; Joep G van Roermund; Evert J van Limbergen; Kees van de Beek; Tom Marcelissen; Victor Zambon; Matthias Oelke; Andre Dekker; Cheryl Roumen; Philippe Lambin; Adriana Berlanga; Rianne Fijten
Journal:  BMC Med Inform Decis Mak       Date:  2019-07-11       Impact factor: 2.796

5.  A global, incremental development method for a web-based prostate cancer treatment decision aid and usability testing in a Dutch clinical setting.

Authors:  Maarten Cuypers; Romy Ed Lamers; Paul Jm Kil; Regina The; Klemens Karssen; Lonneke V van de Poll-Franse; Marieke de Vries
Journal:  Health Informatics J       Date:  2017-07-27       Impact factor: 2.681

6.  Shared decision making, physicians' explanations, and treatment satisfaction: a cross-sectional survey of prostate cancer patients.

Authors:  Kazuhiro Nakayama; Wakako Osaka; Nobuaki Matsubara; Tsutomu Takeuchi; Mayumi Toyoda; Noriyuki Ohtake; Hiroji Uemura
Journal:  BMC Med Inform Decis Mak       Date:  2020-12-14       Impact factor: 2.796

7.  The Effect of an Information Support Program on Self-Efficacy of Prostate Cancer Patients during Hormonal Therapy.

Authors:  Rui Yang; Zhenqi Lu; Xiaofeng Gu; Bo Dai
Journal:  Asia Pac J Oncol Nurs       Date:  2021-10-04

8.  Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.

Authors:  Maarten Cuypers; Romy E D Lamers; Paul J M Kil; Lonneke V van de Poll-Franse; Marieke de Vries
Journal:  Support Care Cancer       Date:  2018-05-12       Impact factor: 3.603

9.  Development and validation of the information needs questionnaire for differentiated thyroid cancer patient with radioactive iodine therapy (INQ-DTC).

Authors:  Jing Zhang; Limei Li; Dongling Liu; Tingting Zhu; Qiaoqiao Gao; Hui Chen; Ling Ma; Jiayin Li; Zichen Wang
Journal:  Nurs Open       Date:  2021-05-18

10.  Differences in treatment choices between prostate cancer patients using a decision aid and patients receiving care as usual: results from a randomized controlled trial.

Authors:  Romy E D Lamers; Maarten Cuypers; Marieke de Vries; Lonneke V van de Poll-Franse; J L H Ruud Bosch; Paul J M Kil
Journal:  World J Urol       Date:  2021-07-17       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.